Task: Answer the multiple-choice question.
Query: Which drug exhibits a 8.811\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. Cc1nn(-c2ccccc2)c(NC(=O)c2ccccc2)c1Br
b. COc1ccc(NC(=O)COC(=O)C2CCN(S(=O)(=O)c3cccs3)CC2)cc1
Answer: a. Cc1nn(-c2ccccc2)c(NC(=O)c2ccccc2)c1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(-c2ccccc2)c(NC(=O)c2ccccc2)c1Br
Cc1nn(-c2ccccc2)c(NC(=O)c2ccccc2)c1Br
N-(4-bromo-5-methyl-2-phenylpyrazol-3-yl)benzamide